- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
2662-8651
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Targeting the PI3K/AKT/mTOR and RAF/MEK/ERK pathways for cancer therapy ; volume:3 ; number:1 ; day:21 ; month:12 ; year:2022 ; pages:1-33 ; date:12.2022
Molecular biomedicine ; 3, Heft 1 (21.12.2022), 1-33, 12.2022
- Urheber
-
Li, Qingfang
Li, Zhihui
Luo, Ting
Shi, Huashan
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1186/s43556-022-00110-2
- URN
-
urn:nbn:de:101:1-2023030320595930878403
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
14.08.2025, 10:50 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Li, Qingfang
- Li, Zhihui
- Luo, Ting
- Shi, Huashan
- SpringerLink (Online service)
Ähnliche Objekte (12)
PI3K-Akt and Raf-MEK-ERK signalling in adipocytes
Dual Inhibition of PI3K-AKT-mTOR- and RAF-MEK-ERK signaling is synergistic in cholangiocarcinoma and reverses acquired resistance to MEK-Inhibitors
Benzimidazoisoquinoline derivatives inhibit glioblastoma cell proliferation through down-regulating Raf/MEK/ERK and PI3K/AKT pathways
Inhibitoren des PI3K/Akt/mTOR und des Ras/MEK/ERK Signalwegs wirken zusammen in der Apoptoseinduktion beim Rhabdomyosarkom
PDCD6 cooperates with C-Raf to facilitate colorectal cancer progression via Raf/MEK/ERK activation
Apatinib affect VEGF-mediated cell proliferation, migration, invasion via blocking VEGFR2/RAF/MEK/ERK and PI3K/AKT pathways in cholangiocarcinoma cell
Modulation of the Akt/Ras/Raf/MEK/ERK pathway by A3 adenosine receptor
Onco-immunomodulatory properties of pharmacological interference with RAS-RAF-MEK-ERK pathway hyperactivation
The EIF3H-HAX1 axis increases RAF-MEK-ERK signaling activity to promote colorectal cancer progression
Human aneuploid cells depend on the RAF/MEK/ERK pathway for overcoming increased DNA damage
Human cerebrovascular contractile receptors are upregulated via a B-Raf/MEK/ERK-sensitive signaling pathway
Bicyclol induces cell cycle arrest and autophagy in HepG2 human hepatocellular carcinoma cells through the PI3K/AKT and Ras/Raf/MEK/ERK pathways
PI3K-Akt and Raf-MEK-ERK signalling in adipocytes
Dual Inhibition of PI3K-AKT-mTOR- and RAF-MEK-ERK signaling is synergistic in cholangiocarcinoma and reverses acquired resistance to MEK-Inhibitors
Benzimidazoisoquinoline derivatives inhibit glioblastoma cell proliferation through down-regulating Raf/MEK/ERK and PI3K/AKT pathways
Inhibitoren des PI3K/Akt/mTOR und des Ras/MEK/ERK Signalwegs wirken zusammen in der Apoptoseinduktion beim Rhabdomyosarkom
PDCD6 cooperates with C-Raf to facilitate colorectal cancer progression via Raf/MEK/ERK activation
Apatinib affect VEGF-mediated cell proliferation, migration, invasion via blocking VEGFR2/RAF/MEK/ERK and PI3K/AKT pathways in cholangiocarcinoma cell
Modulation of the Akt/Ras/Raf/MEK/ERK pathway by A3 adenosine receptor
Onco-immunomodulatory properties of pharmacological interference with RAS-RAF-MEK-ERK pathway hyperactivation
The EIF3H-HAX1 axis increases RAF-MEK-ERK signaling activity to promote colorectal cancer progression
Human aneuploid cells depend on the RAF/MEK/ERK pathway for overcoming increased DNA damage
Human cerebrovascular contractile receptors are upregulated via a B-Raf/MEK/ERK-sensitive signaling pathway
Bicyclol induces cell cycle arrest and autophagy in HepG2 human hepatocellular carcinoma cells through the PI3K/AKT and Ras/Raf/MEK/ERK pathways
PI3K-Akt and Raf-MEK-ERK signalling in adipocytes
Dual Inhibition of PI3K-AKT-mTOR- and RAF-MEK-ERK signaling is synergistic in cholangiocarcinoma and reverses acquired resistance to MEK-Inhibitors
Benzimidazoisoquinoline derivatives inhibit glioblastoma cell proliferation through down-regulating Raf/MEK/ERK and PI3K/AKT pathways
Inhibitoren des PI3K/Akt/mTOR und des Ras/MEK/ERK Signalwegs wirken zusammen in der Apoptoseinduktion beim Rhabdomyosarkom
PDCD6 cooperates with C-Raf to facilitate colorectal cancer progression via Raf/MEK/ERK activation
Apatinib affect VEGF-mediated cell proliferation, migration, invasion via blocking VEGFR2/RAF/MEK/ERK and PI3K/AKT pathways in cholangiocarcinoma cell
Modulation of the Akt/Ras/Raf/MEK/ERK pathway by A3 adenosine receptor
Onco-immunomodulatory properties of pharmacological interference with RAS-RAF-MEK-ERK pathway hyperactivation
The EIF3H-HAX1 axis increases RAF-MEK-ERK signaling activity to promote colorectal cancer progression
Human aneuploid cells depend on the RAF/MEK/ERK pathway for overcoming increased DNA damage
Human cerebrovascular contractile receptors are upregulated via a B-Raf/MEK/ERK-sensitive signaling pathway